Hemmingsen et al [36] compared (ultra-)long-acting insulin analogs versus neutral protamine Hagedorn insulin or other (ultra-)long-acting insulin analogs in patients with type 1 diabetes mellitus. This evidence concerns the gene INS and diabetes mellitus.